Lung Cancer
Conference Coverage
Can benefits of SBRT outweigh risks in ultra-central lung tumors?
Stereotactic body radiotherapy for ultra-central lung tumors offers good disease control and survival but carries a risk of lung hemorrhage.
News
Melatonin not recommended for early-stage NSCLC
There was a hint of benefit with melatonin among patients with stage III/IV NSCLC.
News
FDA scrutinizes cancer therapies granted accelerated approval
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
News
USPSTF expands criteria for lung cancer screening
The population now eligible for lung cancer screening has more than doubled.
News
FDA approves cemiplimab-rwlc for NSCLC with PD-L1 expression
This approval “means physicians and patients have a potent new treatment option against this deadly disease.”
Article
How has the pandemic affected rural and urban cancer patients?
News
FDA approves first drug that protects against chemo-induced myelosuppression
Conference Coverage
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLC
Conference Coverage
Model could reduce some disparities in lung cancer screening
